Press Releases (Page 83)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Orthofix, Spire Global, DexCom, and Methode Electronics and Encourages Investors to Contact the Firm
NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Orthofix Medical Inc. (NASDAQ: OFIX), Spire Global, Inc. (NYSE:SPIR), DexCom, Inc. (NASDAQ: DXCM), and Methode Electronics Inc. (NYSE: MEI). Stockholders have until the deadlines below to petition the court to serve as lead... ❯❯❯
ACADIA HEALTHCARE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Acadia Healthcare Company, Inc. and Encourages Investors to Contact the Firm
NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. (“Acadia Healthcare” or the “Company”) (NASDAQ: ACHC) in the United States District Court Middle District of Tennessee on behalf of all persons and entities who purchased or otherwise acquired Acadia Healthcare... ❯❯❯
Bragar Eagel & Squire, P.C. Is Investigating Winnebago, Visa, and Sun Communities and Encourages Investors to Contact the Firm
NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Winnebago Industries, Inc. (NYSE: WGO), Visa Inc. (NYSE: V), and Sun Communities (NYSE: SUI). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about... ❯❯❯
ADMA BIOLOGICS ALERT: Bragar Eagel & Squire, P.C. is Investigating ADMA Biologics, Inc. on Behalf of ADMA Biologics Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against ADMA Biologics, Inc. (“ADMA Biologics” or the “Company”) (NASDAQ:ADMA) on behalf of ADMA Biologics stockholders. Our investigation concerns whether ADMA Biologics has violated the federal securities laws and/or engaged in other unlawful business practices. Click here... ❯❯❯
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Elanco and UPS and Encourages Investors to Contact the Firm
NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of against Elanco Animal Health Incorporated (NYSE: ELAN) and United Parcel Service, Inc. (NYSE: UPS). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about... ❯❯❯
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Outset Medical, Starbucks, Endava, and Sage and Encourages Investors to Contact the Firm
NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Outset Medical, Inc. (NASDAQ: OM), Starbucks Corporation (NASDAQ:SBUX), Endava PLC (NYSE: DAVA), and Sage Therapeutics, Inc. (NASDAQ: SAGE). Stockholders have until the deadlines below to petition the court to serve as lead... ❯❯❯
EDWARDS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corp and Encourages Investors to Contact the Firm
NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Edwards Lifesciences Corp (“Edwards” or the “Company”) (NYSE: EW) in the United States District Court for the Central District of California on behalf of all persons and entities who purchased or otherwise acquired Edwards securities between February... ❯❯❯
EW BREAKING NEWS: Edwards Lifesciences Corporation has been Sued for Securities Fraud; Investors with Losses are Urged to Contact BFA Law about Class Action Lawsuit (NYSE:EW)
NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investiga... ❯❯❯
TD LEGAL NOTICE: Toronto-Dominion Bank (NYSE:TD) is being Investigated for Securities Fraud for Money Laundering Violations; Investors with Losses are Urged to Contact BFA Law
NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into The Toronto-Dominion Bank (NYSE: TD) for potential violations of the federal securities laws. If you invested in TD Bank, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/the-toronto-dominion-bank. Why Did TD Bank’s Stock Drop? TD Bank... ❯❯❯
DXCM LEGAL NOTICE: DexCom, Inc. is being Sued for Securities Fraud; Investors have Until October 21 to Contact BFA Law before Expiration of Class Action Deadline (Nasdaq:DXCM)
NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM) and certain of the Company’s senior executives. If you invested in DexCom, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/dexcom-inc. Investors have until October 21, 2024 to ask the Court to be... ❯❯❯